Search results
Remdesivir is approved, or authorized for emergency use, to treat COVID‑19 in many countries. [19] Remdesivir has been authorized for emergency use in India, [54] Singapore, [55] and approved for use in Japan, [56] the European Union, the United States, and Australia for people with severe symptoms. [13] [15] [57] [58] [59] [60] [61] [62] [63]
29 kwi 2020 · To answer the first question, remdesivir is owned by Gilead Sciences, a US biotechnology company. Gilead got its first patent for the drug in 2017 when the company was originally targeting it...
7 sie 2020 · Pfizer Inc. (NYSE: PFE) today announced a multi-year agreement with Gilead Sciences, Inc. to manufacture and supply Gilead’s investigational antiviral remdesivir, as one of multiple external manufacturing organizations supporting efforts to scale up supply of the investigational treatment for COVID-19. Under the terms of the agreement, Pfizer ...
28 paź 2020 · On 8 October, the company inked an agreement to supply the European Union with its drug remdesivir as a treatment for COVID-19—a deal potentially worth more than $1 billion. Two weeks later, on 22 October, the U.S. Food and Drug Administration (FDA) approved remdesivir for use against the pandemic coronavirus SARS-CoV-2 in the United States ...
22 kwi 2022 · Pfizer’s oral antiviral drug (a combination of nirmatrelvir and ritonavir tablets) is strongly recommended for patients with non-severe COVID-19 who are at highest risk of developing severe disease and hospitalization, such as unvaccinated, older, or immunosuppressed patients.
18 wrz 2020 · Veklury (remdesivir) is a brand-name drug that's used to treat COVID-19 from coronavirus in hospitalized people. Learn about side effects, cost, and more.
We review clinical development of remdesivir, a prodrug with a demonstrated ability to inhibit SARS-CoV-2 replication, which supports its clinical evaluation for COVID-19 treatment.
